Endicott Emblem
Robert Logan
Assistant Professor of Biology and Biotechnology
亚洲色吧 School of Science and Technology
Contact
Judge Science Center
rlogan@endicott.edu
978-232-2207

Profile

Dr. Logan teaches Anatomy & Physiology, Pathophysiology, Microbiology for Healthcare Professionals, and graduate-level courses in Bioinformatics. His research focuses on ways to improve early diagnosis and treatment of Parkinson's disease. Much of his current work centers on senescence, spatiotemporal multiomics, telomere dynamics, and the role of glia in neurodegeneration. Techniques employed in his lab include bioinformatics, Drosophila models, DNA sequencing, HPLC, and advanced microscopy.

Education

Northeastern University
Ph.D.
Biology

Brandeis University
M.S.
Neuroscience

Fitchburg State University
B.S.
Exercise and Sport Science

Courses

BIO 201/201L - Anatomy and Physiology I and Lab
BIO 202/202L - Anatomy and Physiology II and Lab
BIO 224 - Microbiology for Healthcare Professionals
BIO 335 - Pathophysiology
BIN 620 - Biological Sequence Analysis

Memberships

Sigma Xi, Full Membership

Patents

Logan R., Miller S.J., Schcolnicov N., Williams B.G. 2021. Methods for detecting Amyotrophic Lateral Sclerosis. PCT/US2021/071865, filed October 14th, 2021. Patent pending.

Accomplishments

Awards

  • Faculty Professional Excellence Award, Eastern Nazarene College, 2023.
  • Honorable Mention recipient of the National Science Foundation Graduate Research Fellowship Program.

Publications

  • Logan R., Williams B.G., Da Silva M.F., Indani A., Schcolnicov N., Ganguly A., Miller S.J. Deep convolutional neural networks with ensemble learning and generative adversarial networks for Alzheimer’s disease image data classification. Frontiers in Aging Neuroscience. 2021; 13, 497.
  • Miller J.M., Campbell C.E., Jimenez-Corea H.A., Wu G.H., Logan R. Neuroglial senescence, alpha-synucleinopathy, and the therapeutic potential of senolytics in Parkinson’s disease. Front. Neurosci., 19 April 2022: 514,
  • The Parkinson Study Group SURE-PD Investigators. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb 1;71(2):141-50.